HR+/HER2- Advanced or Metastatic Breast Cancer Patients Treated With Sacituzumab Govitecan
HR+/HER2- Advanced or Metastatic Breast Cancer Patients Treated With Sacituzumab Govitecan
Recruiting · NCT06236269 · Registry updated 2024-07-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HR+/HER2- Advanced or Metastatic Breast Cancer Patients Treated With Sacituzumab Govitecan | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 | 2024-07-19 | NCT06236269 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| SOLTI Breast Cancer Research Group | 20 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fundación Jiménez Díaz | Madrid | Spain | 11 |
| Hospital Clínic de Barcelona | Barcelona | Spain | 55 |
| Hospital Clínico de Valencia | Valencia | Spain | 5 |
| Hospital Sant Joan de Reus | Reus | Spain | 5 |
| Hospital Universitari Vall d'Hebrón | Barcelona | Spain | 19 |
| Hospital Universitario 12 de Octubre | Madrid | Spain | 359 |
| Hospital Universitario Virgen Del Rocio | Seville | Spain | 186 |
| HU Clínico San Cecilio | Granada | Spain | 1 |
| ICO Badalona | Badalona | Spain | 4 |
| ICO Hospitalet | L'Hospitalet de Llobregat | Spain | 1 |